High ‐dose intravenous methotrexate with high‐flux, extended‐hours haemodialysis in treatment of primary central nervous system, post‐transplant lymphoproliferative disorder and end‐stage kidney disease: A case report

Nephrology,Volume 23, Issue 11, Page 1063-1064, November 2018.

Source: Nephrology - October 26, 2018 Category: Urology & Nephrology Authors: James Yeung, Erin Vaughan, Steven Chadban, John Saunders, Nisha Thiagarajah, Christina Brown Source Type: research